Literature DB >> 8635282

Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases.

I Shahar1, E Fireman, M Topilsky, J Grief, S Kivity, Z Spirer, S Ben Efraim.   

Abstract

Alveolar macrophage-fibroblast interaction may be involved in the pathogenesis of interstitial lung diseases (ILD). Herein, we compared IL-6 secretion from alveolar macrophages (AM) and alveolar fibroblasts (AFb) recovered from patients with sarcoidosis (SA) and with diffuse interstitial fibrosis (DIF). Moreover, we evaluated the effect of IL-6 on the in vitro AFb proliferation in both diseases. AM and AFb from SA patients showed increased spontaneous secretion of IL-6 compared with cells from DIF subjects. Tumor necrosis factor-alpha (TNFalpha) and interleukin-1 (IL-1) enhanced IL-6 secretion and IL-6 mRNA transcription in AFb of SA patients. Addition of anti-IL-6 MoAbs increased AFb proliferation capacity in SA, but suppressed it in DIF. These results show that only SA AM and AFb secrete high levels of IL-6 which have suppressive effect on AFb proliferation. This may indicate a potential role of IL-6 in the fibrogenesis of ILD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635282     DOI: 10.1006/clin.1996.0075

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  15 in total

Review 1.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

2.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Eric A Hoffman; Hilary F Armstrong; John H M Austin; Robert C Basner; Matthew N Bartels; Jason D Christie; Paul L Enright; Bernadette R Gochuico; Karen Hinckley Stukovsky; Joel D Kaufman; P Hrudaya Nath; John D Newell; Scott M Palmer; Dan Rabinowitz; Ganesh Raghu; Jessica L Sell; Jered Sieren; Sushil K Sonavane; Russell P Tracy; Jubal R Watts; Kayleen Williams; Steven M Kawut; David J Lederer
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

3.  Therapeutic drug repositioning using personalized proteomics of liquid biopsies.

Authors:  Gabriel Velez; Alexander G Bassuk; Diana Colgan; Stephen H Tsang; Vinit B Mahajan
Journal:  JCI Insight       Date:  2017-12-21

Review 4.  Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis.

Authors:  G Shankar; D A Cohen
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

5.  Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts.

Authors:  L Gallelli; D Falcone; G Pelaia; T Renda; R Terracciano; N Malara; A Vatrella; A Sanduzzi; B D'Agostino; F Rossi; C Vancheri; R Maselli; S A Marsico; R Savino
Journal:  Cell Prolif       Date:  2008-04-24       Impact factor: 6.831

6.  Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation.

Authors:  Yuben P Moodley; Amelia K Scaffidi; Neil L Misso; Carmel Keerthisingam; Robin J McAnulty; Geoff J Laurent; Steven E Mutsaers; Philip J Thompson; Darryl A Knight
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

7.  Effect of montelukast, a cysteinyl receptor antagonist, on myofibroblasts in interstitial lung disease.

Authors:  Elizabeth Fireman; Yehuda Schwartz; Abraham Mann; Joel Greif
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

8.  Preventive effect of halofuginone on concanavalin A-induced liver fibrosis.

Authors:  Jie Liang; Bei Zhang; Ruo-wu Shen; Jia-Bao Liu; Mei-hua Gao; Ying Li; Yuan-Yuan Li; Wen Zhang
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

9.  Sang-qi Granula Reduces Blood Pressure and Myocardial Fibrosis by Suppressing Inflammatory Responses Associated with the Peroxisome Proliferator-Activated Receptors and Nuclear Factor κ B Protein in Spontaneously Hypertensive Rats.

Authors:  Lan-Yu Chen; Chun-Shui Pan; Xiao-Hong Wei; Lin Li; Jing-Yan Han; Li Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-22       Impact factor: 2.629

10.  The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar.

Authors:  Sutapa Ray; Xiaoxi Ju; Hong Sun; Celeste C Finnerty; David N Herndon; Allan R Brasier
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.